Paclitaxel: A Pharmacoeconomic Review of its Use in Non-Small Cell Lung Cancer

By Plosker G.L.   Hurst M.  

PharmacoEconomics, Vol. 19, Iss. 11, 2001-11 ,pp. : 1111-1134

Adis International

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer

By Goto Yasushi  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1548-1556

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer

By Okamoto Isamu   Miyazaki Masaki   Morinaga Ryotaro   Kaneda Hiroyasu   Ueda Shinya   Hasegawa Yoshikazu   Satoh Taroh   Kawada Akira   Fukuoka Masahiro   Fukino Koichi   Tanigawa Takahiko   Nakagawa Kazuhiko  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 844-853

Springer Publishing Company

Access to resources Recommend Favorite

Silencing of X-linked Inhibitor of Apoptosis Decreases Resistance to Cisplatin and Paclitaxel But Not Gemcitabine in Non-small Cell Lung Cancer

By Liu Y   Wu X   Sun Y   Chen F  

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 1682-1692

Field House Publishing

Access to resources Recommend Favorite